(Reuters) -European shares hit a two-week low on Wednesday as elevated equity valuations continued to make investors nervous globally, while Novo Nordisk slipped after the drugmaker issued a dour ...

The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some ...

Investing.com - European stocks traded lower Wednesday, adding to the global selloff in another busy day for corporate ...

Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy are holding back sales at the pharma ...

Stocks fell on Wall Street on Tuesday, pulled down by losses in the same big tech companies that have been the main drivers ...

Dow Jones Top Company Headlines at 3 AM ET: Ozempic Maker Novo Nordisk Lowers Growth Outlook of Its Blockbuster Drugs | Orsted ... Ozempic Maker Novo Nordisk Lowers Growth Outlook of Its Blockbuster ...

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera.

Pedersen and Maggie Fick COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk lowered its full-year profit and sales forecast on ...